🚀 Oscar Health ($OSCR) Rockets 16%: Medicare Expansion & Financial Surge Fuel Rally

Wall Street's latest darling just got a double dose of adrenaline. Oscar Health's stock isn't climbing—it's mooning on policy tailwinds and financial steroids.

The catalyst? A Medicare expansion proposal that's got bulls stampeding. Combine that with earnings that actually impressed (for once), and you've got a recipe for double-digit gains in a single session.

The cynical take: Nothing makes health insurers happier than government-mandated customer acquisition. Meanwhile, retail traders are left wondering if they missed the HMO pump—again.

Active traders are now watching to see if $OSCR can hold these gains—or if this is just another 'sell the news' setup in an overbought market. Either way, someone's getting rich off America's broken healthcare system.

TLDR

• Oscar Health stock rose 16.51% to $18.77 on June 18, 2025, after Medicare Part E proposal news.

• Proposed Part E Medicare plan offers new enrollment options for individuals and employers.

• Company posted a 55% net income rise to $275 million and 42% revenue growth to $3.05 billion.

• Oscar Health expects Q2 earnings of $0.34 per share and revenue of $2.86 billion.

• OSCR maintains focus on ACA marketplace expansion and affordable healthcare innovation.

Oscar Health, Inc. (NYSE: OSCR) stock closed at $18.77 on June 18, 2025, up 16.51%, as investor Optimism soared following news of a proposed Medicare Part E plan. The legislation, if passed, could reshape the health insurance landscape by allowing both individuals and employers to enroll in this alternative Medicare offering.

Oscar Health, Inc. (OSCR)

Medicare Part E Proposal Sparks Interest

The new measure aims to introduce Medicare Part E—a self-funded plan that WOULD exist alongside private insurance across all marketplaces. This proposal holds potential to unlock new enrollment opportunities for Oscar Health, positioning the company as a key player in government-backed health coverage.

Oscar Health $OSCR: A New Kind of Health Insurance Company

Health insurance in the U.S. is usually confusing, expensive, and frustrating. Oscar Health wants to change that and honestly, they might be onto something.

Unlike most health insurance companies, Oscar was built with… pic.twitter.com/eQc36yg62m

— Laurentiu Chisca (@laurentiuchisca) June 19, 2025

Oscar Health executives highlight that nearly 12% of household income is spent on employer-sponsored plans, underlining the need for affordable, flexible healthcare solutions. The company is expected to leverage its extensive ACA marketplace experience to meet this growing demand.

Strong Financial Performance

Oscar Health delivered a stellar financial performance in its most recent quarter. Net income surged 55% year-over-year to $275 million, while revenue climbed 42% to $3.05 billion from $2.14 billion. These results reflect the company’s commitment to scalable and market-leading operations.

The company’s profitability metrics are solid, boasting a profit margin of 1.22%, return on assets of 2.06%, and return on equity of 10.48%. With $2.99 billion in total cash and low debt levels, Oscar maintains financial flexibility for future growth initiatives.

Future Earnings Outlook

Oscar Health’s next earnings report is expected to reveal quarterly earnings of $0.34 per share, a 70% year-over-year improvement. Revenue forecasts suggest a 29% jump to $2.86 billion. However, consensus EPS estimates were revised slightly lower by 0.7% over the past month, indicating cautious analyst sentiment.

Despite the stock’s rally, OSCR carries a Zacks Rank #3 (Hold), reflecting mixed views on near-term performance. Investors are advised to monitor earnings trends closely, as estimate revisions often influence stock movements.

Strategic Growth Plans

Oscar Health’s strategy focuses on enhancing member experiences, advancing technology, and expanding in the ACA individual market. The company aims to introduce innovative products that address evolving healthcare needs while building long-term shareholder value.

Industry Context

Within the insurance sector, Oscar Health outperformed peers like MBIA Inc. (MBI), which closed 2.5% lower recently. MBIA’s lackluster performance and unchanged EPS estimates contrast with Oscar’s upward earnings trajectory.

In summary, Oscar Health stands at a promising juncture. The Medicare Part E proposal and robust financial results could propel the stock higher if the company sustains its growth momentum. Investors remain watchful for legislative outcomes and upcoming earnings data to gauge future prospects.